1 | A bill to be entitled |
2 | An act relating to independent diagnostic testing |
3 | facilities; creating part XIV of chapter 400, F.S.; |
4 | providing a popular name; providing legislative findings; |
5 | providing definitions; providing licensing requirements; |
6 | providing application requirements and deadlines; |
7 | providing for temporary licensure; requiring background |
8 | screening of all applicants; restricting the issuance of |
9 | licenses under certain circumstances; providing for fees; |
10 | providing for inspections of facilities by the Agency for |
11 | Health Care Administration; providing for emergency |
12 | suspension of licenses; providing for administrative fines |
13 | and investigation fees; requiring license renewal and |
14 | providing requirements thereof; requiring application for |
15 | change of ownership under certain circumstances and |
16 | providing requirements thereof; restricting transfers of |
17 | licenses; providing for provisional licenses in certain |
18 | circumstances; requiring the agency to adopt rules; |
19 | requiring the agency to calculate certain fees; providing |
20 | requirements; providing for deposit of collected fees in |
21 | the Health Care Trust Fund; providing that it is unlawful |
22 | to own, operate, or maintain a facility without a license; |
23 | providing criminal penalties; providing for fines; |
24 | providing penalties for health care providers who fail to |
25 | report unlicensed facilities under certain circumstances; |
26 | requiring the president, director, medical director, or |
27 | chief executive officer of each independent diagnostic |
28 | testing facility to accept certain responsibilities; |
29 | requiring new independent diagnostic testing facilities to |
30 | apply for licensure within a certain timeframe; |
31 | restricting eligibility of certain claims; providing |
32 | penalties for unlicensed activity; providing penalties for |
33 | health care providers in violation; providing authority to |
34 | the agency to suspend or revoke licenses issued; providing |
35 | for investigations for compliance; providing for exemption |
36 | from licensure under certain circumstances; requiring |
37 | independent diagnostic testing facilities to display |
38 | licenses; requiring accreditation for licensure; granting |
39 | full faith and credit to magnetic resonance imaging |
40 | independent diagnostic testing facilities under certain |
41 | circumstances; authorizing the agency to pursue injunctive |
42 | relief under certain circumstances; providing criteria; |
43 | providing for a standard of review for agency actions; |
44 | authorizing administrative penalties and providing |
45 | criteria thereof; providing for procedures to correct |
46 | violations; providing for interest on administrative |
47 | fines; providing fines; providing for plans of corrective |
48 | action in certain circumstances; providing for deposit of |
49 | administrative fines in the Health Care Trust Fund; |
50 | providing an effective date. |
51 |
|
52 | Be It Enacted by the Legislature of the State of Florida: |
53 |
|
54 | Section 1. Part XIV of chapter 400, Florida Statutes, |
55 | consisting of sections 400.9970, 400.9971, 400.9972, 400.9973, |
56 | 400.9974, 400.9975, 400.9976, 400.9977, 400.9978, 400.9979, and |
57 | 400.9980, Florida Statutes, is created to read: |
58 | 400.9970 Popular name; legislative findings.-- |
59 | (1) This part may be referred to by the popular name the |
60 | "Independent Diagnostic Testing Facility Act." |
61 | (2) The Legislature finds that the regulation of |
62 | independent diagnostic testing facilities must be strengthened |
63 | to prevent significant cost and harm to consumers. The purpose |
64 | of this part is to provide for the licensure, establishment, and |
65 | enforcement of basic standards for independent diagnostic |
66 | testing facilities and to provide for the administrative |
67 | oversight of such testing facilities by the Agency for Health |
68 | Care Administration. |
69 | 400.9971 Definitions.--As used in this part: |
70 | (1) "Agency" means the Agency for Health Care |
71 | Administration. |
72 | (2) "Applicant" means an individual, partnership, |
73 | corporation, or other business entity that owns or controls 5 |
74 | percent or more of an interest in the independent diagnostic |
75 | testing facility, but does not include the limited partners in |
76 | limited liability partnerships or an individual who is |
77 | responsible for the day-to-day operation or financial operation |
78 | of the independent diagnostic testing facility. |
79 | (3) "Independent diagnostic testing facility" means an |
80 | individual, partnership, corporation, or other business entity |
81 | that performs the technical components of magnetic resonance |
82 | imaging, static radiographs, computer tomography, and position |
83 | emission tomography, and provides the professional components of |
84 | such services, in a fixed facility that is accredited by the |
85 | Joint Commission on Accreditation of Healthcare Organizations |
86 | and the American College of Radiology within 1 year after |
87 | licensure and: |
88 | (a) Does not accept patient referrals prohibited by s. |
89 | 456.053(5). |
90 | (b) Does not directly or indirectly provide therapy or |
91 | treatment services to patients for whom it also provides |
92 | diagnostic imaging services. |
93 | (c) Does not include any entity which has an investor as |
94 | defined by s. 456.053(3) or include any one of the following: |
95 | 1. Any individual or entity that is directly or indirectly |
96 | an investor in a clinic; or |
97 | 2. Any individual or entity that directly or indirectly |
98 | provides services to a clinic if such services include the |
99 | referral of patients to any provider of diagnostic imaging |
100 | services as defined in s. 456.053(3). |
101 | (d) Is not a clinic as defined in s. 400.9905. |
102 | 400.9972 License requirements; background screenings; |
103 | prohibitions.-- |
104 | (1) Each independent diagnostic testing facility shall be |
105 | licensed and maintain a valid license with the agency. Each |
106 | independent diagnostic testing facility location shall be |
107 | licensed separately even if the independent diagnostic testing |
108 | facility is operated under the same business name or management |
109 | as another independent diagnostic testing facility. |
110 | (2) The initial independent diagnostic testing facility |
111 | license application shall be filed with the agency by all |
112 | independent diagnostic testing facilities on or before March 1, |
113 | 2005. An independent diagnostic testing facility license shall |
114 | be renewed biennially. |
115 | (3) Applicants that submit an application on or before |
116 | March 1, 2005, which meets all requirements for initial |
117 | licensure shall receive a temporary license until the completion |
118 | of an initial inspection verifying that the applicant meets all |
119 | requirements in the rules authorized by s. 400.9975. However, a |
120 | clinic engaged in magnetic resonance imaging services may not |
121 | receive a temporary license unless it presents evidence |
122 | satisfactory to the agency that such clinic is making a good |
123 | faith effort and substantial progress in seeking accreditation |
124 | required under s. 400.9935. |
125 | (4) Application for an initial independent diagnostic |
126 | testing facility license or for renewal of an existing license |
127 | shall be notarized on forms furnished by the agency and shall be |
128 | accompanied by the appropriate license fee as specified in s. |
129 | 400.9975. The agency shall take final action on an initial |
130 | license application within 60 days after receipt of all required |
131 | documentation. |
132 | (5) The application shall contain information that |
133 | includes, but need not be limited to, the name, residence and |
134 | business addresses, phone numbers, social security number, and |
135 | license number of each applicant and each licensed medical |
136 | provider employed or under contract with the independent |
137 | diagnostic testing facility. |
138 | (6) The application shall include satisfactory proof that |
139 | the independent diagnostic testing facility is in compliance |
140 | with this part and applicable rules, including the number and |
141 | discipline of each professional staff member to be employed. |
142 | (7) Upon receipt of a completed, signed, and dated |
143 | application, the agency shall require background screening of |
144 | the applicant, in accordance with the level 2 standards for |
145 | screening set forth in chapter 435. Proof of compliance with the |
146 | level 2 background screening requirements of chapter 435 which |
147 | has been submitted within the previous 5 years in compliance |
148 | with any other health care licensure requirements of this state |
149 | is acceptable in fulfillment of this subsection. |
150 | (8) Each applicant shall submit with the application a |
151 | description and explanation of any exclusions, permanent |
152 | suspensions, or terminations of an applicant from the Medicare |
153 | or Medicaid program. Proof of compliance with the requirements |
154 | for disclosure of ownership and control interest under the |
155 | Medicaid or Medicare program may be accepted in lieu of this |
156 | submission. The description and explanation may indicate whether |
157 | such exclusions, suspensions, or terminations were voluntary or |
158 | involuntary on the part of the applicant. |
159 | (9) A license may not be granted to an independent |
160 | diagnostic testing facility if the applicant has been found |
161 | guilty of, or has entered a plea of nolo contendere or guilty |
162 | to, any offense prohibited under the level 2 standards for |
163 | screening set forth in chapter 435, or a violation of insurance |
164 | fraud under s. 817.234, within the past 5 years. If the |
165 | applicant has been convicted of an offense prohibited under the |
166 | level 2 standards or insurance fraud in any jurisdiction, the |
167 | applicant shall show that his or her civil rights have been |
168 | restored prior to submitting an application. |
169 | (10) The agency may deny or revoke licensure if the |
170 | applicant has falsely represented any material fact or omitted |
171 | any material fact from the application required by this part. |
172 | (11) Requested information omitted from an application for |
173 | licensure, license renewal, or transfer of ownership shall be |
174 | filed with the agency within 21 days after receipt of the |
175 | agency's request for omitted information or the application |
176 | shall be deemed incomplete and withdrawn from further |
177 | consideration. |
178 | (12) The failure to file a timely renewal application |
179 | shall result in a late fee charged to the independent diagnostic |
180 | testing facility in an amount equal to 50 percent of the current |
181 | license fee. |
182 | 400.9973 Independent diagnostic testing facility |
183 | inspections; emergency suspension; costs.-- |
184 | (1) An authorized officer or employee of the agency shall |
185 | make inspections of the independent diagnostic testing facility |
186 | as part of the initial license application or renewal |
187 | application. The application for an independent diagnostic |
188 | testing facility license or renewal issued under this part |
189 | constitutes permission for an appropriate agency inspection to |
190 | verify the information submitted in connection with the |
191 | application or renewal. |
192 | (2) An authorized officer or employee of the agency may |
193 | make unannounced inspections of independent diagnostic testing |
194 | facilities licensed pursuant to this part as are necessary to |
195 | determine that such facilities are in compliance with this part |
196 | and with applicable rules. A licensed independent diagnostic |
197 | testing facility shall allow full and complete access to the |
198 | premises and to billing records or information to any |
199 | representative of the agency who makes an inspection to |
200 | determine compliance with this part and with applicable rules. |
201 | (3) Failure by an independent diagnostic testing facility |
202 | licensed under this part to allow full and complete access to |
203 | the premises and to billing records or information to any |
204 | representative of the agency who makes a request to inspect the |
205 | independent diagnostic testing facility to determine compliance |
206 | with this part constitutes grounds for emergency suspension of |
207 | the license by the agency pursuant to s. 120.60(6). |
208 | (4) In addition to any administrative fines imposed, the |
209 | agency may assess a fee equal to the cost of conducting a |
210 | complaint investigation. |
211 | 400.9974 License renewal; transfer of ownership; |
212 | provisional license.-- |
213 | (1) An application for license renewal shall contain |
214 | information as required by the agency. |
215 | (2) An application for license renewal shall be submitted |
216 | to the agency 90 days before the expiration date of the license. |
217 | (3) The independent diagnostic testing facility shall file |
218 | with the license renewal application satisfactory proof that it |
219 | is in compliance with this part and applicable rules. |
220 | (4) When transferring the ownership of an independent |
221 | diagnostic testing facility, the transferee shall submit an |
222 | application for a license at least 60 days before the effective |
223 | date of the transfer. An application for change of ownership of |
224 | an independent diagnostic testing facility is required only when |
225 | 45 percent or more of the ownership, voting shares, or |
226 | controlling interest of an independent diagnostic testing |
227 | facility is transferred or assigned, including the final |
228 | transfer or assignment of multiple transfers or assignments over |
229 | a 2-year period that cumulatively total 45 percent or more. |
230 | (5) The license may not be sold, leased, assigned, or |
231 | otherwise transferred and is valid only for the independent |
232 | diagnostic testing facility owners and location for which |
233 | originally issued. |
234 | (6) An independent diagnostic testing facility against |
235 | whom a revocation or suspension proceeding is pending at the |
236 | time of license renewal may be issued a provisional license |
237 | until final disposition by the agency of such proceedings. If |
238 | judicial relief is sought from the final disposition, the agency |
239 | may issue a temporary license for the duration of the judicial |
240 | proceeding. |
241 | 400.9975 Rulemaking authority; license fees.-- |
242 | (1) The agency shall adopt rules necessary to administer |
243 | the independent diagnostic testing facility administration, |
244 | regulation, and licensure program, including rules establishing |
245 | the specific licensure requirements, procedures, forms, and |
246 | fees. The agency shall adopt rules establishing a procedure for |
247 | the biennial renewal of licenses. The agency may issue initial |
248 | licenses for less than the full 2-year period by charging a |
249 | prorated licensure fee and specifying a different renewal date |
250 | than would otherwise be required for biennial licensure. The |
251 | rules shall specify the expiration dates of licenses and any |
252 | other conditions of renewal. |
253 | (2) License application and renewal fees shall be |
254 | reasonably calculated by the agency to cover the agency's costs |
255 | in carrying out the agency's responsibilities under this part, |
256 | including the cost of licensure, inspection, and regulation of |
257 | independent diagnostic testing facilities, and shall be of such |
258 | amount that the total fees collected do not exceed the cost of |
259 | administering and enforcing compliance with this part. |
260 | Independent diagnostic testing facility licensure fees are |
261 | nonrefundable and may not exceed $2,000. The agency shall adjust |
262 | the license fee annually by not more than the change in the |
263 | Consumer Price Index based on the 12 months immediately |
264 | preceding the increase. All fees collected under this part shall |
265 | be deposited in the Health Care Trust Fund for the |
266 | administration of this part. |
267 | 400.9976 Unlicensed independent diagnostic testing |
268 | facilities; penalties; fines; verification of licensure |
269 | status.-- |
270 | (1) It is unlawful to own, operate, or maintain an |
271 | independent diagnostic testing facility without obtaining a |
272 | license under this part. |
273 | (2) Any person who owns, operates, or maintains an |
274 | unlicensed independent diagnostic testing facility commits a |
275 | felony of the third degree, punishable as provided in s. |
276 | 775.082, s. 775.083, or s. 775.084. Each day of continued |
277 | operation is a separate offense. |
278 | (3) Any person who violates subsection (2) a second or |
279 | subsequent time commits a felony of the second degree, |
280 | punishable as provided in s. 775.082, s. 775.083, or s. 775.084. |
281 | Each day of continued operation is a separate offense. |
282 | (4) Any person who owns, operates, or maintains an |
283 | unlicensed independent diagnostic testing facility due to a |
284 | change in this part or a modification in agency rules within 6 |
285 | months after the effective date of such change or modification |
286 | and who, within 10 working days after receiving notification |
287 | from the agency, fails to cease operation or apply for a license |
288 | under this part commits a felony of the third degree, punishable |
289 | as provided in s. 775.082, s. 775.083, or s. 775.084. Each day |
290 | of continued operation is a separate offense. |
291 | (5) Any independent diagnostic testing facility that fails |
292 | to cease operation after agency notification may be fined for |
293 | each day of noncompliance pursuant to this part. |
294 | (6) Any person aware of the operation of an unlicensed |
295 | independent diagnostic testing facility shall report that |
296 | facility to the agency. |
297 | (7) Any health care provider who is aware of the operation |
298 | of an unlicensed independent diagnostic testing facility shall |
299 | report that facility to the agency. Failure to report an |
300 | independent diagnostic testing facility that the provider knows |
301 | or has reasonable cause to suspect is unlicensed shall be |
302 | reported to the provider's licensing board. |
303 | (8) The agency may not issue a license to an independent |
304 | diagnostic testing facility that has any unpaid fines assessed |
305 | under this part. |
306 | 400.9977 Independent diagnostic testing facility |
307 | responsibilities.-- |
308 | (1) The president, director, medical director, or chief |
309 | executive officer of each independent diagnostic testing |
310 | facility shall agree in writing to accept legal responsibility |
311 | for the following activities on behalf of the independent |
312 | diagnostic testing facility: |
313 | (a) Ensuring that all practitioners providing health care |
314 | services or supplies to patients maintain a current active and |
315 | unencumbered Florida license. |
316 | (b) Reviewing any patient referral contracts or agreements |
317 | executed by the independent diagnostic testing facility. |
318 | (c) Ensuring that all health care practitioners at the |
319 | independent diagnostic testing facility have active, appropriate |
320 | certification or licensure for the level of care being provided. |
321 | (d) Serving as the independent diagnostic testing facility |
322 | records owner as defined in s. 456.057. |
323 | (e) Ensuring compliance with the recordkeeping, office |
324 | surgery, and adverse incident reporting requirements of chapter |
325 | 456, the respective practice acts, and rules adopted under this |
326 | part. |
327 | (f) Conducting systematic reviews of independent |
328 | diagnostic testing facility billings to ensure that the billings |
329 | are not fraudulent or unlawful. Upon discovery of an unlawful |
330 | charge, the medical director or independent diagnostic testing |
331 | facility director shall take immediate corrective action. |
332 | (2) Any business that becomes an independent diagnostic |
333 | testing facility after commencing operations shall, within 5 |
334 | days after becoming an independent diagnostic testing facility, |
335 | file a license application under this part and shall be subject |
336 | to all provisions of this part applicable to an independent |
337 | diagnostic testing facility. |
338 | (3) All charges or reimbursement claims made by or on |
339 | behalf of an independent diagnostic testing facility that is |
340 | required to be licensed under this part but that is not so |
341 | licensed, or that is otherwise operating in violation of this |
342 | part, are unlawful charges and therefore are noncompensable and |
343 | unenforceable. |
344 | (4) Any person establishing, operating, or managing an |
345 | unlicensed independent diagnostic testing facility otherwise |
346 | required to be licensed under this part, or any person who |
347 | knowingly files a false or misleading license application or |
348 | license renewal application, or false or misleading information |
349 | related to such application or department rule, commits a felony |
350 | of the third degree, punishable as provided in s. 775.082, s. |
351 | 775.083, or s. 775.084. |
352 | (5) Any licensed health care provider who violates this |
353 | part is subject to discipline in accordance with this chapter |
354 | and his or her respective practice act. |
355 | (6) The agency may fine, or suspend or revoke the license |
356 | of, any independent diagnostic testing facility licensed under |
357 | this part for operating in violation of the requirements of this |
358 | part or the rules adopted by the agency. |
359 | (7) The agency shall investigate allegations of |
360 | noncompliance with this part and the rules adopted under this |
361 | part. |
362 | (8) Any person or entity providing health care services |
363 | which is not an independent diagnostic testing facility may |
364 | voluntarily apply for a certificate of exemption from licensure |
365 | under its exempt status with the agency on a form that sets |
366 | forth its name, or names and addresses, a statement of the |
367 | reasons it cannot be defined as an independent diagnostic |
368 | testing facility, and other information deemed necessary by the |
369 | agency. |
370 | (9) The independent diagnostic testing facility shall |
371 | display its license in a conspicuous location within the |
372 | independent diagnostic testing facility readily visible to all |
373 | patients. |
374 | (10)(a) In order to remain licensed, an independent |
375 | diagnostic testing facility shall be accredited by the Joint |
376 | Commission on Accreditation of Healthcare Organizations and the |
377 | American College of Radiology within 1 year after licensure. |
378 | However, an independent diagnostic testing facility may request |
379 | a single, 6-month extension if it provides evidence to the |
380 | agency establishing that, for good cause shown, such independent |
381 | diagnostic testing facility cannot be accredited within 1 year |
382 | after licensure and that such accreditation will be completed |
383 | within the 6-month extension. After obtaining accreditation as |
384 | required by this paragraph, each such independent diagnostic |
385 | testing facility shall maintain accreditation as a condition of |
386 | renewal of its license. |
387 | (b) The agency may disallow the application of any entity |
388 | formed for the purpose of avoiding compliance with the |
389 | accreditation provisions of this subsection and whose principals |
390 | were previously principals of an entity that was unable to meet |
391 | the accreditation requirements within the specified timeframes. |
392 | The agency may adopt rules as to the accreditation of magnetic |
393 | resonance imaging independent diagnostic testing facilities. |
394 | (11) The agency shall give full faith and credit |
395 | pertaining to any past variance and waiver granted to a magnetic |
396 | resonance imaging independent diagnostic testing facility from |
397 | Rule 64-2002, Florida Administrative Code, by the Department of |
398 | Health, until September 1, 2004. After that date, such |
399 | independent diagnostic testing facility shall request a variance |
400 | and waiver from the agency under s. 120.542. |
401 | 400.9978 Injunctions.-- |
402 | (1) The agency may institute injunctive proceedings in a |
403 | court of competent jurisdiction in order to: |
404 | (a) Enforce the provisions of this part or any minimum |
405 | standard, rule, or order issued or entered into pursuant to this |
406 | part if the attempt by the agency to correct a violation through |
407 | administrative fines has failed; if the violation materially |
408 | affects the health, safety, or welfare of independent diagnostic |
409 | testing facility patients; or if the violation involves any |
410 | operation of an unlicensed independent diagnostic testing |
411 | facility. |
412 | (b) Terminate the operation of an independent diagnostic |
413 | testing facility if a violation of any provision of this part, |
414 | or any rule adopted pursuant to this part, materially affects |
415 | the health, safety, or welfare of independent diagnostic testing |
416 | facility patients. |
417 | (2) Such injunctive relief may be temporary or permanent. |
418 | (3) If action is necessary to protect independent |
419 | diagnostic testing facility patients from life-threatening |
420 | situations, the court may allow a temporary injunction without |
421 | bond upon proper proof being made. If it appears by competent |
422 | evidence or a sworn, substantiated affidavit that a temporary |
423 | injunction should be issued, the court, pending the |
424 | determination on final hearing, shall enjoin operation of the |
425 | independent diagnostic testing facility. |
426 | 400.9979 Agency actions.--Administrative proceedings |
427 | challenging agency licensure enforcement action shall be |
428 | reviewed on the basis of the facts and conditions that resulted |
429 | in the agency action. |
430 | 400.9980 Agency administrative penalties.-- |
431 | (1) The agency may impose administrative penalties against |
432 | independent diagnostic testing facilities of up to $5,000 per |
433 | violation for violations of the requirements of this part. In |
434 | determining whether a penalty is to be imposed and in fixing the |
435 | amount of the fine, the agency shall consider the following |
436 | factors: |
437 | (a) The gravity of the violation, including the |
438 | probability that death or serious physical or emotional harm to |
439 | a patient will result or has resulted, the severity of the |
440 | action or potential harm, and the extent to which the provisions |
441 | of the applicable laws or rules were violated. |
442 | (b) Actions taken by the owner, medical director, or |
443 | independent diagnostic testing facility director to correct |
444 | violations. |
445 | (c) Any previous violations. |
446 | (d) The financial benefit to the independent diagnostic |
447 | testing facility of committing or continuing the violation. |
448 | (2) Each day of continuing violation after the date fixed |
449 | for termination of the violation, as ordered by the agency, |
450 | constitutes an additional, separate, and distinct violation. |
451 | (3) Any action taken to correct a violation shall be |
452 | documented in writing by the owner, medical director, or |
453 | independent diagnostic testing facility director and verified |
454 | through followup visits by agency personnel. The agency may |
455 | impose a fine and, in the case of an owner-operated independent |
456 | diagnostic testing facility, revoke or deny an independent |
457 | diagnostic testing facility's license when an independent |
458 | diagnostic testing facility medical director or independent |
459 | diagnostic testing facility director fraudulently misrepresents |
460 | actions taken to correct a violation. |
461 | (4) For fines that are upheld following administrative or |
462 | judicial review, the violator shall pay the fine, plus interest |
463 | at the rate as specified in s. 55.03, for each day beyond the |
464 | date set by the agency for payment of the fine. |
465 | (5) Any unlicensed independent diagnostic testing facility |
466 | that continues to operate after agency notification is subject |
467 | to a $1,000 fine per day. |
468 | (6) Any independent diagnostic testing facility whose |
469 | owner fails to apply for a change-of-ownership license in |
470 | accordance with s. 400.9974 and operates the independent |
471 | diagnostic testing facility under the new ownership is subject |
472 | to a fine of $5,000. |
473 | (7) The agency, as an alternative to or in conjunction |
474 | with an administrative action against an independent diagnostic |
475 | testing facility for violations of this part and adopted rules, |
476 | shall, prior to written notification, make a reasonable attempt |
477 | to discuss each violation and recommended corrective action with |
478 | the owner, director, or medical director of the independent |
479 | diagnostic testing facility. The agency, instead of fixing a |
480 | period within which the independent diagnostic testing facility |
481 | shall enter into compliance with standards, may request a plan |
482 | of corrective action from the independent diagnostic testing |
483 | facility which demonstrates a good faith effort to remedy each |
484 | violation by a specific date, subject to the approval of the |
485 | agency. |
486 | (8) Administrative fines paid by any independent |
487 | diagnostic testing facility under this section shall be |
488 | deposited into the Health Care Trust Fund. |
489 | Section 2. This act shall take effect July 1, 2004. |